Anti-CD197/CCR7 Polyclonal Antibody from ProteoGenix; catalogue ARO-A22109; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Introducing the Anti-CD197/CCR7 Polyclonal Antibody – Your Solution for Targeted Biotech Research
Are you in need of a reliable and effective tool for your biotech research? Look no further than our Anti-CD197/CCR7 Polyclonal Antibody. This powerful antibody is specifically designed to target the CD197/CCR7 protein, making it an essential tool for immunology and cancer research.
The biological function of CD197/CCR7 is crucial in the immune system, as it plays a key role in the migration of immune cells to lymph nodes. This process is essential for the body’s defense against infections and diseases. Our Anti-CD197/CCR7 Polyclonal Antibody binds to the CD197/CCR7 protein with high specificity, allowing for precise and accurate detection.
The main applications of our Anti-CD197/CCR7 Polyclonal Antibody include flow cytometry, immunohistochemistry, and Western blotting. It is suitable for use in both human and animal samples, making it a versatile choice for various research projects. With a high affinity and sensitivity, this antibody ensures reliable and reproducible results.
But the benefits of our Anti-CD197/CCR7 Polyclonal Antibody don’t stop there. It has been extensively tested and validated in various experimental use cases, including cancer research, autoimmune diseases, and vaccine development. Its effectiveness in these areas makes it a valuable tool for any biotech researcher.
ProteoGenix catalogue number ARO-A22109. For research use only.
Target: C-C chemokine receptor type 7; C-C CKR-7; CC-CKR-7; CCR-7; Epstein-Barr virus-induced G-protein coupled receptor 1; EBI1; EBV-induced G-protein coupled receptor 1; MIP-3 beta receptor; CD197; Ccr7; Cmkbr7; Ebi1; Ebi1h; Clonality: Polyclonal Antibody; Applications: ELISA, IHC.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| C-C chemokine receptor type 7; C-C CKR-7; CC-CKR-7; CCR-7; Epstein-Barr virus-induced G-protein coupled receptor 1; EBI1; EBV-induced G-protein coupled receptor 1; MIP-3 beta receptor; CD197; Ccr7; Cmkbr7; Ebi1; Ebi1h |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
